Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Monte Rosa Therapeutics, Inc
Duke University
AstraZeneca
Fred Hutchinson Cancer Center
Complement Theory Inc.
City of Hope Medical Center
NeoTX Therapeutics Ltd.
UNICANCER
Pfizer
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Theratechnologies
Memorial Sloan Kettering Cancer Center
Agenus Inc.
Carisma Therapeutics Inc
NGM Biopharmaceuticals, Inc
Intuitive Surgical
NGM Biopharmaceuticals, Inc